Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F4633
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,030,579
Award facts
- Contract value 100% obligated
- $1,030,579.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain issued a $1,030,579.20 delivery order to Teva Pharmaceuticals USA, Inc. on April 15, 2026, for Adenovirus Type 4 vaccine with an ultimate completion date of April 29, 2026.
Place of performance is Parsippany, NJ. The order is firm fixed price with no set-aside designation. Teva serves as prime contractor with no subcontractors on this engagement.
Quick answers
Who was awarded contract SPE2DP26F4633?
SPE2DP26F4633 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on April 15, 2026.
How much is contract SPE2DP26F4633 worth?
The government has obligated $1,030,579 on SPE2DP26F4633.
Is contract SPE2DP26F4633 an order under another contract?
Yes. SPE2DP26F4633 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F4633 competed?
The extent of competition for SPE2DP26F4633 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award